Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

FLAME study shows enhanced stroke recovery with fluoxetine

May 27, 2011

Nexvax-2 vaccine is safe and bioactive in phase I trial in celiac disease

May 27, 2011

Findings disclosed from two phase II trials of NXL-104/ceftazidime

May 27, 2011

Preclinical data support further development of PF-4348235 for treatment of COPD

May 27, 2011

LIPN gene mutation correlates with late-onset autosomal recessive ichthyosis

May 27, 2011

Monoclonal antibody against beta-amyloid reduces symptoms of AMD in vivo

May 26, 2011

New selective glucocorticoid receptor antagonists prevent olanzapine-induced weight gain in vivo

May 26, 2011

MGMTP140K gene-modified cells are safe and confer chemoprotection in phase I/II glioblastoma trial

May 26, 2011

New vaccine targeting morphine dependency shows promise in rats

May 26, 2011

Ongoing phase I/II trial suggests safety of CDCA1-A24-56 vaccine in patients with CRPC

May 26, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...